Articles tagged with 'cancer research' | Cedars-Sinai Medical Center

When added to standard chemotherapy, a clinical version of the dietary supplement L-glutamine improved survival in an early-phase trial of patients with advanced pancreatic cancer. The study, led by Cedars-Sinai Health Sciences University …

Donations to Cedars-Sinai surpassed $200 million at the close of fiscal year 2026, a milestone now reached only three times in the medical center’s 124-year history. Grateful patients donated most of the gifts.During FY 2026, which ended June 30, …

Cedars-Sinai Health Sciences University investigators have identified a protein that helps repair damage to the bone marrow after chemotherapy and radiation.The protein restores the blood stem cell niche—the specialized environment that supports …

Women who test negative for BRCA gene mutations may still be at greater risk of developing breast cancer than the general population, according to a study led by Cedars-Sinai Health Sciences University investigators. The findings, published in JAMA …

Cedars-Sinai Cancer investigators have identified metabolites produced by gut bacteria that help the body’s immune system fight cancer. These chemicals, called indoles, are produced when the bacteria break down nutrients, and their identification …

A team led by Cedars-Sinai Health Sciences University investigators has developed a tool for matching breast cancer patients with the most effective presurgical treatments. Called BRIDGE, the tool is the first of its kind and is described in  Annals …

A new medication could double survival time in patients with advanced pancreatic cancer, according to Phase III clinical trial results presented at the American Society of Clinical Oncology (ASCO) 2026 annual meeting and simultaneously published in …

Physician-scientists from Cedars-Sinai Cancer and The Angeles Clinic and Research Institute, an affiliate of Cedars-Sinai, will present translational research designed to improve patient care and outcomes during the American Society of Clinical …

A team led by Cedars-Sinai Health Sciences University investigators has created a faster, cheaper way to determine the genes expressed in cancerous tumors. The AI-based tool, which they describe in Cell, could make personalized cancer treatment …

Cedars-Sinai Cancer physicians and scientists will share the latest advances in cancer science and medicine at the American Association for Cancer Research (AACR) Annual Meeting April 17-22 in San Diego.Through more than 20 talks, panels, symposia …

Microbes in the gut use specialized chemical signaling molecules to communicate, and one day, these molecules may help doctors understand which ulcerative colitis patients are most likely to develop colon cancer. In a study co-led by researchers at …

A new tool co-developed by investigators from Cedars-Sinai Health Sciences University can predict which of two available chemotherapy options for pancreatic cancer would be more effective for an individual patient.If validated in further studies, …

A new Cedars-Sinai Cancer study shows that patients with advanced liver cancer who receive immunotherapy to shrink their tumors have improved outcomes after liver transplant or tumor removal.The study, published in the journal Liver Cancer, found …

Eytan Ruppin, MD, PhD, who pioneers artificial intelligence-based methods for predicting individual patients’ response to cancer therapies, has joined Cedars-Sinai Cancer as deputy director of the Translational Research Institute. He will also serve …

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in clinical trials to cut the risk of death by more than 40%.The combination therapy, which adds a drug called enzalutamide to …

Cedars-Sinai investigators led an update of staging guidelines for HPV-positive throat cancer—now more common in the U.S. than cervical cancer, according to the American Cancer Society—that will make treatment of early-stage disease more consistent …

When cancer cells in male patients and immune cells in their tumors both lose the Y chromosome, those patients tend to experience poorer outcomes than patients without Y chromosome loss, according to new findings from Cedars-Sinai investigators. …

Colorectal tumors can vary in molecular mutations among individuals and communities, according to a new study from Cedars-Sinai Cancer. Investigators reporting in the peer-reviewed journal Cancer Research concluded that these differences could guide …

A unique protein designed by Cedars-Sinai Cancer investigators can cross the protective blood-brain barrier safely and deliver therapy directly into cancerous tumor cells, a preclinical study shows. The findings, which could help clinicians target …

Ze’ev Ronai, PhD, a prominent cancer investigator and director of the Translational Research Institute at Cedars-Sinai, has received an Outstanding Investigator Award from the National Cancer Institute. This is the second time that Ronai has …

Cedars-Sinai Cancer investigators led a data analysis on more than 6 million patients in the Veterans Health Administration system and concluded that Black patients were twice as likely as white patients to develop prostate cancer. The study, …

A study led by Cedars-Sinai investigators provides new evidence that thyroid cancer continues to be overdiagnosed and that aggressive screening and treatment of thyroid cancer has not led to higher survival rates.The research was published in the …

A new study from Cedars-Sinai Cancer reveals a potential way to overcome tumor resistance to a common chemotherapy drug called cisplatin.The study, published in the peer-reviewed journal Science Advances, could improve the effectiveness of the …

Cedars-Sinai investigators who previously developed an imaging tool that used artificial intelligence (AI) to predict pancreatic cancer are now working to adapt that tool specifically for Black patients, who have disproportionately high rates of the …

A group of investigators led by Cedars-Sinai have developed and successfully tested a new artificial intelligence (AI) method to make launching cancer clinical trials easier and faster. The method uses patients’ pathology reports to automate the …

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments that carry risks of side effects that can significantly reduce the quality of life without extending life, …

Several major oncology groups, led by Cedars-Sinai Cancer investigators, have published a white paper in The Lancet Oncology recommending clinical trial designs that can improve testing of new drug-radiotherapy combinations and speed the regulatory …

A syndrome called cachexia, which triggers unexplained loss of weight and muscle mass, causes severe illness and death among patients with cancer and other serious health conditions. Cachexia (pronounced kuh·kek’·see·uh) can also be one of the …

Cedars-Sinai Cancer is advancing its commitment to diversity in research by participating in the largest-ever national study of cancer risk factors in Asian Americans. Investigators are hoping to learn why Asian Americans have disproportionately …

Radiation therapy is part of the standard treatment for advanced lung cancer, but can cause heart rhythm abnormalities, also called arrhythmias.In a study published in the peer-reviewed journal JACC: CardioOncology, Cedars-Sinai and Harvard …